- Raised $500k funding round, Oct 2025
- Raised $1M grant, Dec 2024
- Raised $400k funding round, May 2024
About
Chronic conditions like cancer and endometriosis remain difficult to diagnose accurately due to the limitations of current imaging tools. Cancer is the most misdiagnosed of the 'big three' conditions, and 75% of endometriosis patients receive an incorrect diagnosis and are forced to undergo diagnostic surgery. While MRI and PET-CT often miss small findings, ultrasound is highly operator-dependent and inconsistent, leaving a critical gap in the early and reliable detection of disease.
Revealan™, our robotic ultrasound imaging platform, seamlessly integrates with any off-the-shelf ultrasound device to enable operator-agnostic, automated, AI-enabled, high-resolution 3D imaging. The robotic scan output is a series of standardized medical images with a density 10 times higher than that of an MRI. With Revealan™, we allow early detection and reliable follow-ups of small findings. Revealan™ is optimizing ultrasound for better patient outcomes.
Funding history · 6 rounds · $2.5M total
Q&A
- What is EndoCure's primary focus?
- EndoCure is transforming an off-the-shelf ultrasound into an AI-enabled, objective, high-resolution 3D tool for diagnosing chronic conditions like cancer and endometriosis.
- What is EndoCure's flagship product?
- EndoCure's flagship product is Revealan™, a robotic ultrasound imaging platform that integrates with existing ultrasound devices to provide operator-agnostic, automated, AI-enabled, high-resolution 3D imaging.
- When was EndoCure founded?
- EndoCure was founded in November 2023.
- What is EndoCure's total funding raised to date?
- EndoCure has raised a total of $2,550,000 USD.
- When did EndoCure receive its most recent funding?
- In October 2025, EndoCure received $500,000 USD from IL Investors Forum.
- Which investors participated in EndoCure's May 2024 funding round?
- In May 2024, EndoCure received $400,000 USD from MassChallenge Israel and Teuza.
- Who are the co-founders of EndoCure?
- The co-founders of EndoCure are Hadas Ziso, who also serves as CEO, and Moshe Shoham.
- What is the current product stage of EndoCure?
- EndoCure's product is currently in the clinical trial stage.
Team · 2
Sectors & technology
Highlights
Tags
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | endocure.tech/ |
|---|---|
| linkedin.com/company/100036964 |
Identifiers & details
| Founded | 2023-11 |
|---|---|
| Employees (exact) | 5 |
| Offices | Boston |
Radar intelligence
Patents
| EPO | 2 |
|---|
Web history (Wayback)
| Domain | endocure.tech |
|---|
Certificate / subdomain footprint
| Subdomains | 3 |
|---|